VolitionRx Limited Schedules Second Quarter 2022 Earnings Conference Call and Business Update Aug 8, 2022 04:10PM
Salarius Pharmaceuticals and VolitionRx Enter into R&D Collaboration Agreement Aug 2, 2022 08:30AM
VolitionRx Limited Announces First Quarter 2022 Financial Results and Business Update May 11, 2022 04:10PM
VolitionRx Limited Schedules First Quarter 2022 Earnings Conference Call and Business Update May 6, 2022 08:00AM
VolitionRx Limited to Host Capital Markets Day on Friday May 13 May 5, 2022 08:03AM
View Older Stories

Apr 25, 2022 08:00AM Volition Launches its Nu.Q® Vet Cancer Test in Asia Through its Appointed Distributor SAGE Healthcare
Apr 6, 2022 08:00AM Volition appoints Sharon Ballesteros as U.S. Head of Quality and Development Process
Mar 30, 2022 04:10PM VolitionRx Limited Announces Full Fiscal Year 2021 Financial Results and Business Update
Mar 28, 2022 04:25PM VolitionRx Limited Schedules Full Fiscal Year 2021 Earnings Conference Call and Business Update
Jan 20, 2022 08:30AM Volition presents study data at ASCO GI 2022 on circulating nucleosomes for the detection of colorectal cancer and high-risk advanced adenomas
Dec 16, 2021 08:00AM Volition Executes its First Supply and Licensing Contract for its Nu.Q® Vet Cancer Screening Test in Asia
Nov 10, 2021 04:10PM VolitionRx Limited Announces Third Quarter 2021 Financial Results and Business Update
Nov 8, 2021 08:30AM VolitionRx Limited Schedules Third Quarter 2021 Earnings Conference Call and Business Update
Nov 4, 2021 08:33AM Volition Veterinary Presents Two Posters at the 2021 Veterinary Cancer Society Conference
Aug 11, 2021 04:10PM VolitionRx Limited Announces Second Quarter 2021 Financial Results and Business Update
Aug 4, 2021 08:15AM VolitionRx Limited Schedules Second Quarter 2021 Earnings Conference Call and Business Update
Jul 22, 2021 08:00AM Volition's Nu.Q® NETs Assay Demonstrates Promising Results in COVID-19 Risk Stratification and Disease Monitoring
Jun 21, 2021 08:35AM VolitionRx Limited to Webcast Live at Life Sciences Investor Forum June 24th
May 11, 2021 04:10PM VolitionRx Limited Announces First Quarter 2021 Financial Results and Business Update
May 6, 2021 08:15AM VolitionRx Limited Schedules First Quarter 2021 Earnings Conference Call and Business Update
Mar 31, 2021 08:30AM VolitionRx Limited Announces Publication of Significant Nu.Q® Capture Mass Spectrometry Paper
Mar 30, 2021 08:30AM VolitionRx Limited Appoints Dr. Tom Butera DVM as Chief Executive Officer for Volition Veterinary Subsidiary
Mar 29, 2021 04:10PM VolitionRx Limited Appoints Two New Directors
Mar 22, 2021 04:10PM VolitionRx Limited Announces Full Fiscal Year 2020 Financial Results and Business Update
Mar 22, 2021 08:35AM VolitionRx Limited to Webcast Live at Life Sciences Investor Forum March 25th
Mar 17, 2021 08:00AM New Data Demonstrates Nu.Q® is Effective in Monitoring Treatment of Sepsis
Mar 16, 2021 08:30AM VolitionRx Limited Schedules Full Fiscal Year 2020 Earnings Conference Call and Business Update
Mar 8, 2021 04:15PM VolitionRx Limited to Present at Conferences in March 2021
Feb 10, 2021 09:30AM Pre-Open Stock Movers 02/10: (TLRY) (GMDA) (CMLF) Higher; (VNRX) (CPST) (XONE) Lower (more...)
Feb 9, 2021 06:01PM After-Hours Stock Movers 02/09: (GNFT) (MODN) (USNA) Higher; (VNRX) (XONE) (LMB) Lower (more...)
Feb 2, 2021 07:46AM Volitionrx Limited (VNRX) Provides a Business Update and Appoints Key Officers to Drive Commercialization Efforts
Feb 2, 2021 07:45AM VolitionRx Provides a Business Update and Appoints Key Officers to Drive Commercialization Efforts
Feb 1, 2021 03:29PM VolitionRx Limited to Webcast Live at VirtualInvestorConferences.com February 4th
Jan 28, 2021 06:21AM National Taiwan University Hospital Presents Data on Nu.Q™ Assay Performance at the World Conference on Lung Cancer
Jan 25, 2021 08:45AM VolitionRx Limited Opens its New Manufacturing Facility in Belgium
Jan 6, 2021 08:25AM Volitionrx Limited (VNRX) Awarded an Additional $4 Million in Non-Dilutive Funding
Jan 6, 2021 08:25AM VolitionRx Limited Awarded an Additional $4 Million in Non-Dilutive Funding
Dec 3, 2020 08:33AM Volitionrx Limited (VNRX) Announces Dr. Tom Butera DVM to Board
Dec 3, 2020 08:30AM VolitionRx Limited Appoints Dr. Tom Butera DVM to Board of Directors
Dec 1, 2020 08:45AM Volition Launches Nu.Q™ Vet Cancer Screening Test in the U.S.
Nov 19, 2020 07:00AM VolitionRx Limited to Present COVID-19 Data at MEDICA 2020
Nov 12, 2020 04:10PM VolitionRx Limited Announces Third Quarter 2020 Financial Results and Business Update
Nov 10, 2020 08:00AM Volition Veterinary Presents Expert Report Ahead of First Product Launch
Nov 9, 2020 08:00AM VolitionRx Limited Schedules Third Quarter 2020 Earnings Conference Call and Business Update
Oct 21, 2020 08:00AM VolitionRx Limited Releases Video of Virtual Capital Markets Day 2020
Oct 20, 2020 07:00AM VolitionRx Limited Announces Details for Virtual Capital Markets Day 2020
Oct 16, 2020 08:00AM Volition Veterinary Diagnostics Development LLC Announces Product Data Regarding its Nu.Q™ Vet Cancer Screening Test in Lymphoma and Hemangiosarcoma to be Presented at the 2020 VCS Virtual Annual Co
Oct 14, 2020 08:00AM VolitionRx Limited Announces Details for Virtual Capital Markets Day 2020
Oct 12, 2020 08:00AM Volition Veterinary Diagnostics Development LLC to Present Product Data Regarding its Nu.Q™ Vet Cancer Screening Test at the 2020 VCS Virtual Annual Conference
Sep 29, 2020 08:00AM VolitionRx Limited Announces Virtual Capital Markets Day 2020
Sep 1, 2020 08:00AM VolitionRx Limited to Present at Conferences in September 2020
Aug 13, 2020 04:10PM VolitionRx Limited Announces Second Quarter 2020 Financial Results and Business Update
Aug 10, 2020 07:30AM VolitionRx Limited Schedules Second Quarter 2020 Earnings Conference Call and Business Update
Jul 14, 2020 06:03AM Volitionrx Limited (VNRX) Reports 'Promising' Clinical Trials Results for its Novel COVID-19 Triage Test
Jul 14, 2020 06:00AM Volition Announces Promising Clinical Trials Results for its Novel COVID-19 Triage Test
View Older Stories